Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III study of H008 tablets versus lansoprazole in duodenal ulcer
ChiCTR2100043457Phase 3Recruiting
- Sponsor
- The First Affiliated Hospital of Sun Yat-sen University
- Start
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of keverprazan in duodenal ulcer (2 arms), sponsored by The First Affiliated Hospital of Sun Yat-sen University. Primary endpoint: Duodenal ulcer healing. Started Jul 2020; status: recruiting.
02
Drugs
keverprazan
03
Conditions
duodenal ulcer
Beyond the preview
Go deeper on ChiCTR2100043457.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100043457.